Suchergebnisse - "Liu, Fangming"

PubPharm (5)

1

Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancer

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2022

von Liu, F. | Gai, X. | Wu, Y. | +12

2

eIF4A1 Inhibitor Suppresses Hyperactive mTOR-Associated Tumors by Inducing Necroptosis and G2/M Arrest

enthalten in: International journal of molecular sciences | 2022

von Han, L. | Wu, Y. | Liu, F. | +1

3

xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade

enthalten in: Cell death & disease | 2022

von Tang, B. | Zhu, J. | Liu, F. | +12

4

αB-crystallin/HSPB2 is critical for hyperactive mTOR-induced cardiomyopathy

enthalten in: Journal of cellular physiology | 2021

von Wang, L. | Wang, F. | Liu, K. | +11

5

mTOR/miR-145-regulated exosomal GOLM1 promotes hepatocellular carcinoma through augmented GSK-3β/MMPs

enthalten in: Journal of genetics and genomics = Yi chuan xue bao | 2019

von Gai, X. | Tang, B. | Liu, F. | +7

1
[1]